Logo print RMMS Rakoczy Molino Mazzochi Siwik LLP
  • About
  • Services
  • Profiles
  • News
  • Contact
  • X
  • News

News

Federal Circuit Affirms Invalidity Judgment Concerning Zymaxid®/Zymar® (Gatifloxacin) Ophthalmic Solutions

03/20/2015

RMMS Files Supreme Court Amicus Brief on Behalf of GPhA Supporting Specific-Intent-to-Infringe Requirement for Induced Infringement

02/26/2015

RMMS Secures Judgment of Patent Invalidity Following Remand Trial Involving Generic Pulmicort Respules® (Budesonide Inhalation Suspension)

02/13/2015

Federal Circuit Affirms Judgment Of Non-Infringement Involving Generic Trizivir® (Abacavir Sulfate, Lamivudine, and Zidovudine) Tablets

02/12/2015

RMMS Recognized as Industry Leaders by LMG Life Sciences

11/07/2014

RMMS Secures Reversal Before Federal Circuit, Invalidating Asserted Patents Concerning Latisse® (bimatoprost) Ophthalmic Solution

07/10/2014

U.S. Court Of Appeals For The Federal Circuit Affirms RMMS's Victory Involving Generic Ibandronate Products

04/11/2014

RMMS Secures Judgment Of Non-Infringement After A Trial Involving Generic Trizivir® (Abacavir Sulfate; Lamivudine; Zidovudine) Tablets

12/17/2013

RMMS Secures Judgment Of Patent Invalidity After A Trial Involving Gatifloxacin Ocular Formulation and Method

08/09/2013

Federal Circuit Affirms Judgment Of Non-Infringement Involving Generic Mometasone Furoate Nasal Spray

06/10/2013
Newer 1 2 3 4 5 6 7 Older

Services

  • Litigation
    • Small Molecules and Biologics
    • Regulatory Litigation
    • Representative Matters
    • Litigation Highlights
  • Patent Counseling
  • Regulatory Counseling
    • About
    • Services
    • Profiles
    • News
    • Contact
    • Disclaimers
    • Copyright © 2022 Rakoczy Molino Mazzochi Siwik LLP